Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Madrigal Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 380
- 0 vs. Q4 2025
- Shares held
- 23.8M
- +2.21M (+10.3%) vs. Q4 2025
- Total value
- $12.4B
- −$105.9M (−0.8%) vs. Q4 2025
- New holders
- 63
- 131 more added
- Sold out
- 63
- 129 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 414 | $12.7B |
| Q1 2026 | 380 | $12.4B |
| Q4 2025 | 387 | $13.7B |
| Q3 2025 | 352 | $10.7B |
| Q2 2025 | 305 | $7.13B |
| Q1 2025 | 321 | $7.85B |
| Q4 2024 | 283 | $7.08B |
| Q3 2024 | 257 | $4.77B |
| Q2 2024 | 257 | $6.41B |
| Q1 2024 | 266 | $5.64B |
| Q4 2023 | 226 | $4.57B |
| Q3 2023 | 206 | $2.54B |
| Q2 2023 | 208 | $3.43B |
| Q1 2023 | 223 | $3.36B |
| Q4 2022 | 189 | $3.86B |
| Q3 2022 | 135 | $763.2M |
| Q2 2022 | 138 | $857.7M |
| Q1 2022 | 140 | $1.20B |
| Q4 2021 | 144 | $1.01B |
| Q3 2021 | 133 | $876.5M |
| Q2 2021 | 151 | $1.09B |
| Q1 2021 | 137 | $1.43B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Madrigal Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −3,632−100.0% | Sold out |
| CWM Advisors, LLC | 0 | $0 | 0.00% | −2,256−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −1,997−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −1,571−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −1,513−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,336−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −1,062−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −1,041−100.0% | Sold out |
| Cynosure Management, LLC | 0 | $0 | 0.00% | −1,025−100.0% | Sold out |
| Optimize Financial Inc | 0 | $0 | 0.00% | −992−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −902−100.0% | Sold out |
| IFG Advisory, LLC | 0 | $0 | 0.00% | −844−100.0% | Sold out |
| QRG Capital Management, Inc. | 0 | $0 | 0.00% | −834−100.0% | Sold out |
| PharVision Advisers, LLC | 0 | $0 | 0.00% | −813−100.0% | Sold out |
| Vestmark Advisory Solutions, Inc. | 0 | $0 | 0.00% | −806−100.0% | Sold out |
| Cary Street Partners Financial LLC | 0 | $0 | 0.00% | −628−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −536−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| SummitTX Capital, L.P. | 0 | $0 | 0.00% | −433−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −427−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −430−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −393−100.0% | Sold out |
| RSM US Wealth Management LLC | 0 | $0 | 0.00% | −381−100.0% | Sold out |
| Callan Family Office, LLC | 0 | $0 | 0.00% | −366−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −352−100.0% | Sold out |
| Destination Wealth Management | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −155−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −112−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Quattro Advisors LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| MV Capital Management, Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Vermillion & White Wealth Management Group, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Cape Investment Advisory, Inc. | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Retirement Wealth Solutions LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Cary Street Partner Investment Advisory LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Motiv8 Investments LLC | – | – | – | – | Not filed |